P3 Health Partners shareholders approve warrant exercise for 3.3M shares

Filed June 10, 2026 · Period ending June 9, 2026 · ~1 min read

Key Changes

• medium

  Shareholders authorized issuance of up to 3,341,130 Class A shares upon exercise of warrants held by VBC Growth SPV 5, LLC, representing potential dilution to existing holders.

  Item 5.07: Warrant Authorization verify on EDGAR →
• low

  Three Class II directors elected to serve until 2029 annual meeting: Dr. Amir Bacchus, Mark Thierer, and Lawrence B. Leisure.

  Item 5.07: Director Elections verify on EDGAR →
• low

  BDO USA, P.C. ratified as independent auditor for fiscal year 2026 with over 99% approval.

  Item 5.07: Auditor Ratification verify on EDGAR →